Triple-Negative Breast Cancer Research and Education Act of 2023

Summary

Triple-Negative Breast Cancer Research and Education Act of 2023 This bill requires research and education activities related to triple-negative breast cancer. The cells of these breast cancers are negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so they do not respond to hormonal therapy medicines or medicines that target the HER2 protein receptors. Specifically, the National Institutes of Health must conduct and support research into the disease. Additionally, the Centers for Disease Control and Prevention and the Health Resources and Services Administration must develop information about triple-negative breast cancer, including information regarding the elevated risk for minority women, for the public and for health care providers.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 10 January 2023

   Introduced

   Referred to the House Committee on Energy and Commerce.

   Source: IntroReferral

2. 10 January 2023

   Introduced

   Introduced in House

   Source: IntroReferral

3. 10 January 2023

   Introduced

   Introduced in House

   Source: IntroReferral

4. 20 January 2023

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 10 January 2023 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 10 January 2023

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 10 January 2023

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 10 January 2023

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Jackson Lee, Sheila [D-TX-18] · D · Sponsor
• Rep. Moore, Gwen [D-WI-4] · D · Cosponsor
• Rep. Morelle, Joseph D. [D-NY-25] · D · Cosponsor
• Rep. Bacon, Don [R-NE-2] · R · Cosponsor
• Rep. Tonko, Paul [D-NY-20] · D · Cosponsor
• Rep. Williams, Nikema [D-GA-5] · D · Cosponsor
• Rep. Ivey, Glenn [D-MD-4] · D · Cosponsor
• Rep. Evans, Dwight [D-PA-3] · D · Cosponsor
• Rep. Carter, Troy A. [D-LA-2] · D · Cosponsor
• Rep. Jackson, Jonathan L. [D-IL-1] · D · Cosponsor
• Rep. Moskowitz, Jared [D-FL-23] · D · Cosponsor
• Rep. Sewell, Terri A. [D-AL-7] · D · Cosponsor
• Rep. Cherfilus-McCormick, Sheila [D-FL-20] · D · Cosponsor
• · hsif00 · Standing

Related records

• related to ← Triple-Negative Breast Cancer Research and Education Act of 2021